TY  - JOUR

T1  - Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.

JO  - Prostate

PY  - 2004/05/15

AU  - Eaton CL

AU  - Wells JM

AU  - Holen I

AU  - Croucher PI

AU  - Hamdy FC

ED  - 

DO  - DOI: 10.1002/pros.20016

VL  - 59

IS  - 3

SP  - 304

EP  - 310

Y2  - 2024/12/21

ER  -